Ajax-Loading

Sino Biopharmaceutical Ltd - Current Deferred Revenue

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.The Serie's long term average value is 1.09 Billion Hong Kong Dollars. It's latest available value, on 03/31/2024, is -1.08 Billion Hong Kong Dollars lower, compared to it's long term average value.
The Serie's change in Hong Kong Dollars from it's minimum value, on 06/30/2012, to it's latest available value, on 03/31/2024, is +0.0856 Billion.
The Serie's change in percent from it's maximum value, on 06/30/2023, to it's latest available value, on 03/31/2024, is -99.92%.

Current Deferred Revenue for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Current Deferred Revenue905,699,262,464.00
LogoJohnson & Johnson - Current Deferred Revenue486,508,953,600.00
LogoAbbVie Inc - Current Deferred Revenue399,570,305,024.00
LogoRoche Holding AG - Current Deferred Revenue317,433,206,677.55
LogoAstraZeneca PLC - Current Deferred Revenue280,205,508,085.11